ZYBERNO
Stock Report
Updated Sep 1, 2026

Immutep Limited (IMMP)

Healthcare • NASDAQ

$0.37

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
21.0/100
POOR BUSINESS
Immutep Limited (IMMP) scores 21/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (0.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Immutep Limited (IMMP) stock report — Zyberno Score 21/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.37
Market Cap:$69.51M

Valuation Multiples (3)

P/B Ratio:0.69x
P/S Ratio:9.54x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$21.98M
Ev Ebitda Ratio:102.84x

Price Action & Momentum (1)

% of 52-Week High:77.9%
B. Profitability Assessment

Margin Analysis (1)

Ebitda Margin:2.9%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:11.69x
Quick Ratio:11.69x
Cash Ratio:5.28x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:0.00x

Coverage Ratios (2)

Interest Coverage Ratio:0.00x
Times Interest Earned:0.00

Capital Structure (4)

Working Capital:96,139,726.09
Cash And Cash Equivalents:47,533,374.66
Long Term Debt:$0.00
Net Debt:-$47.53M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$7.29M
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00$0.00

Bottom Line Performance (3)

-$43.32M
Income Before Tax:$0.00
Ebitda Ttm:213,721.10

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:0.00
Sga Expense:0.00
Income Tax Expense:$0.00
Interest Expense:26,145.81

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:0.0%
Ebitda Margin:2.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$110.70M
Current Assets:$105.14M
Ppe Net:44,747.85
Goodwill:0.00
Intangible Assets:$5.08M

Liability Structure (4)

Total Liabilities:9,412,485.70
Current Liabilities:8,996,988.16
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$101.29M
Retained Earnings:$0.00
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:6,958,762.88
Inventory:0.00
Accounts Payable:3,902,098.38

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$43.75M-$43.79M

Investment Activities (1)

Investing Cash Flow:-$27.17M

Financing Activities (3)

Financing Cash Flow:-$370.29K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$0.23

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.04
Operating Cash Flow Per Share:-$0.23

Book Value & Capital (2)

Book Value Per Share:$0.53
Cash Per Share:0.25

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.07x
Working Capital Turnover Ttm:0.08x

Receivables Management (2)

Receivables Turnover Ttm:1.05x
Days Sales Outstanding Ttm:348.64

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:195.50
Cash Conversion Cycle:-845.86
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:IMMP
Company Name:Immutep Limited
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:Australia

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:189.92M
Shares Outstanding Basic:0
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 01:43:35 UTC
Data Timestamp:2026-08-20T07:55:35.831909
Scroll to Top